Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10231 |
| Vaccine Name | VLA1533 |
| Disease Name | Chikungunya fever |
| Disease Classification | Exanthous |
| Virus Name | Chikungunya virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Phase 1 |
| Manufacturer | Valneva |
| Year of Manufacturing | 2019 |
| Manufacturing Country | Austria |
| Age | 18 - 39 years |
| Dosage | 3 doses on day 0, 28 and 56 |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT03010228 |
| Reference Link | https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 |
| Additional Links | https://clinicaltrials.gov/ct2/show/NCT03010228 |